Net Cash Provided by (Used in) Operating Activities |
410M |
USD |
+20.9% |
Q4 2023 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-811M |
USD |
-1101% |
Q4 2023 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
429M |
USD |
|
Q4 2023 |
Q1 2024 |
Common Stock, Shares, Issued |
2.5K |
shares |
0% |
Q3 2024 |
FY 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
29.9M |
USD |
-92.1% |
Q4 2023 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
1.79B |
USD |
+10.8% |
Q3 2024 |
FY 2024 |
Deferred Tax Assets, Valuation Allowance |
4.6M |
USD |
-54.9% |
Q3 2024 |
FY 2024 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
540M |
USD |
-5.76% |
Q3 2024 |
FY 2024 |
Deferred Income Tax Expense (Benefit) |
-20.1M |
USD |
-43.6% |
Q4 2023 |
Q1 2024 |
Preferred Stock, Shares Authorized |
10K |
shares |
0% |
Q3 2024 |
FY 2024 |
Unrecognized Tax Benefits |
59.8M |
USD |
+34.7% |
Q3 2024 |
FY 2024 |
Depreciation, Depletion and Amortization |
173M |
USD |
+1.71% |
Q4 2023 |
Q1 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
194M |
USD |
+31% |
Q3 2024 |
FY 2024 |
Interest Expense |
2.49B |
USD |
+48.9% |
Q3 2024 |
FY 2024 |
Preferred Stock, Par or Stated Value Per Share |
1 |
USD/shares |
0% |
Q3 2024 |
FY 2024 |